PKM and neoplasm: Interestingly, it was seen that iHCC1 and iHCC2 cluster tumours use liver-specific PKLR for the utilisation of pyruvate rather than the muscle isoform PKM, signifying metabolic dysregulation on multiple pathways, indicative of more advanced or aggressive cancer.